ANEB icon

Anebulo Pharmaceuticals

12 hedge funds and large institutions have $17.1M invested in Anebulo Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

11% less capital invested

Capital invested by funds: $19.2M → $17.1M (-$2.09M)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$388
2 +$41

Top Sellers

1 -$9.34K
2 -$2.63K
3 -$2.54K
4
Morgan Stanley
Morgan Stanley
New York
-$2K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$12.3M
2
$1.63M
3
$1.24M
4
$968K
5
$436K
6
$375K
7
$71.8K
8
$42K
9
$17.7K
10
$9K
11
$4.1K
12
$131
13